The removal of a large KKR overhang is a modest positive for the stock, but the secondary itself is a neutral event for BridgeBio's fundamentals. Monitor for any subsequent insider selling or changes in institutional ownership post-offering.
Price Chart
Executive Summary
KKR Genetic Disorder L.P. is selling 5,000,000 shares of BridgeBio common stock at $78.00 per share in an underwritten secondary offering. BridgeBio receives no proceeds, but the transaction diversifies its shareholder base and removes a large overhang from a major institutional holder. The offering is expected to close on August 17, 2026, with a 30-day lock-up on the selling stockholder.
Key Facts
- KKR Genetic Disorder L.P. is selling 5,000,000 shares of BBIO common stock at $78.00 per share.
- BridgeBio will not receive any proceeds from the offering.
- The offering is oversubscribed and priced at $78.00 per share, with underwriters paying $77.415 per share.
- Underwriters include William Blair, Goldman Sachs, and KKR Capital Markets.
- The selling stockholder is subject to a 30-day lock-up agreement.
- The offering is expected to close on August 17, 2026.
Financial Impact
Secondary offering of 5,000,000 shares at $78.00 per share; gross proceeds of $390 million to the selling stockholder. BridgeBio receives $0.
Risk Factors
- No direct financial benefit to BridgeBio from the offering.
- Potential for further selling by other large holders if the lock-up expiration leads to distribution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-033282 |
| Document: ef20080234_8k.htm | 0001140361-26-033282 |
| Document: ef20080234_ex99-2.htm | 0001140361-26-033282 |
| Document: ef20080234_ex5-1.htm | 0001140361-26-033282 |
| Document: ef20080234_ex99-1.htm | 0001140361-26-033282 |
| Document: 0001140361-26-033282-index-headers.html | 0001140361-26-033282 |
| Document: 0001140361-26-033282-index.html | 0001140361-26-033282 |
| Document: 0001140361-26-033282.txt | 0001140361-26-033282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $76.59 $65.97 | ▼ −13.87% | ▼ −13.68% | $67.47 (−11.90%) |
Aug 26, 2026 5w ago | Press Release | $79.37 $66.28 | ▼ −16.49% | ▼ −16.72% | $67.47 (−14.99%) |
Aug 22, 2026 5w ago | Institutional Cluster | $81.07 $69.23 | ▼ −14.60% | ▼ −15.92% | $67.47 (−16.77%) |
Aug 17, 2026 6w ago | 8-K | $79.89 $72.38 | ▼ −9.40% | ▼ −7.87% | $67.47 (−15.54%) |
Aug 13, 2026 7w ago | Press Release | $79.86 $72.38 | ▲ +9.37% | ▲ +7.38% | $67.47 (+15.51%) |
Aug 10, 2026 7w ago | 8-K | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Aug 10, 2026 7w ago | Press Release | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Jul 13, 2026 11w ago | Insider Cluster | $83.08 $84.67 | ▲ +1.91% | ▼ −1.27% | $67.47 (−18.78%) |
Jun 28, 2026 13w ago | Press Release | $72.01 $84.02 | ▲ +16.68% | ▲ +16.96% | $67.47 (−6.30%) |
Jun 24, 2026 14w ago | 144 | $69.69 $82.93 | ▲ +19.00% | ▲ +18.47% | $67.47 (−3.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access